Stomach cancer: The ‘warning’ signs when you go to the toilet - symptoms often 'dismissed'

STOMACH cancer can often go undetected. Early symptoms of stomach cancer can be like symptoms of common stomach conditions.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Conclusion. Nutritional support via feeding enterosto my for more than 90 days after esophagectomy was required in 23.5% of patients. The elderly, poor performance status, and lower body weight were the independent preoperative factors for predicting the long-term placement of feeding enterostomy.
Source: Annals of Nutrition and Metabolism - Category: Nutrition Source Type: research
Curr Ther Res Clin Exp. 2021 Dec 16;96:100659. doi: 10.1016/j.curtheres.2021.100659. eCollection 2022.ABSTRACTBACKGROUND: Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non-small cell lung cancer, and prostate cancer.OBJECTIVE: This is a Phase IV study to evaluate the safety profile of docetaxel (Alvotere; NanoAlvand, Iran) in Iranian patients diagnosed with different types of cancers receiving chemotherapy regimens with docetaxel.METHODS: Patients who received Alvotere as a part of their chemotherapy reg...
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Source Type: research
J Oncol. 2022 Jan 6;2022:6708871. doi: 10.1155/2022/6708871. eCollection 2022.ABSTRACTGastric cancer (GC) is among the most prevalent causes of cancer-related death globally. MiR-223 has been implicated in a variety of cellular mechanisms linked to cancer progression. However, the miR-223 expressions and its function in GC are unknown. We discovered that miR-223 expression was raised in GC tissues in comparison with nearby normal tissues in this investigation. Additionally, multiplied miR-223 expression was strongly linked with TNM stage (p=0.022), live metastasis (p=0.004),lymph node metastasis (p=0.004),and Borrmann type...
Source: Journal of Oncology - Category: Cancer & Oncology Authors: Source Type: research
Curr Ther Res Clin Exp. 2021 Dec 16;96:100659. doi: 10.1016/j.curtheres.2021.100659. eCollection 2022.ABSTRACTBACKGROUND: Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non-small cell lung cancer, and prostate cancer.OBJECTIVE: This is a Phase IV study to evaluate the safety profile of docetaxel (Alvotere; NanoAlvand, Iran) in Iranian patients diagnosed with different types of cancers receiving chemotherapy regimens with docetaxel.METHODS: Patients who received Alvotere as a part of their chemotherapy reg...
Source: Cell Research - Category: Cytology Authors: Source Type: research
In this study, we extracted and characterized H. pylori OMVs of two strains (standard strain NCTC11637 and clinical strain Hp-400) and analyzed the specific content by proteomic technology. We identified more than 400 proteins in H. pylori OMVs. In addition, we investigated the impact of H. pylori OMVs on cellular functions by detecting proteomic changes in GES1 cells. GES1 cells cocultured with increasing concentrations of H. pylori OMVs were subjected to quantitative proteomic analyses using label-free methods for relative quantitation. The results showed that a total of 4261 proteins were verified, 153 of which were sig...
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research
Curr Ther Res Clin Exp. 2021 Dec 16;96:100659. doi: 10.1016/j.curtheres.2021.100659. eCollection 2022.ABSTRACTBACKGROUND: Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non-small cell lung cancer, and prostate cancer.OBJECTIVE: This is a Phase IV study to evaluate the safety profile of docetaxel (Alvotere; NanoAlvand, Iran) in Iranian patients diagnosed with different types of cancers receiving chemotherapy regimens with docetaxel.METHODS: Patients who received Alvotere as a part of their chemotherapy reg...
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Source Type: research
CONCLUSIONS: Our data demonstrated that the overexpression of IL-8 and Wnt2 could be isolated prognostic factors in patients with GC and, possibly, may present new targets for the treatment of GC.PMID:35037695 | DOI:10.5603/FHC.a2022.0002
Source: Folia Histochemica et Cytobiologica - Category: Cytology Authors: Source Type: research
Curr Ther Res Clin Exp. 2021 Dec 16;96:100659. doi: 10.1016/j.curtheres.2021.100659. eCollection 2022.ABSTRACTBACKGROUND: Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non-small cell lung cancer, and prostate cancer.OBJECTIVE: This is a Phase IV study to evaluate the safety profile of docetaxel (Alvotere; NanoAlvand, Iran) in Iranian patients diagnosed with different types of cancers receiving chemotherapy regimens with docetaxel.METHODS: Patients who received Alvotere as a part of their chemotherapy reg...
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Source Type: research
CONCLUSION: HOXC-AS3 may increase NSCLC cell growth and invasion by sponging premature miR-96 to suppress its maturation.PMID:35034519 | DOI:10.1080/17476348.2022.2030223
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research
Gastric cancer is the fifth most common type of human cancer and the third leading cause of cancer-related death. The purpose of this study is to investigate the immune infiltration signatures of gastric cancer and their relation to prognosis. We identified two distinct subtypes of gastric cancer (C1/C2) characterized by different immune infiltration signatures. C1 is featured by immune resting, epithelial–mesenchymal transition, and angiogenesis pathways, while C2 is featured by enrichment of the MYC target, oxidative phosphorylation, and E2F target pathways. The C2 subtype has a better prognosis than the C1 subtype...
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Health